🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › New York › Rochester

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Rochester, NY keessatti

Qorannoo 13 Kansara Qara'a Non-Small Cell f Rochester fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • Rochester General Hospital, Rochester
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Namoota walitti qabaa jiraSadarkaa 3
  • Wilmot Cancer Institute ( Site 0141), Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190248

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06868277

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester Medical Center, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06561386

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Rochester General Hospital Infectious Disease, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07100080

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06686771

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • University of Rochester, Rochester
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT06139627

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Namoota walitti qabaa jiraSadarkaa 3
  • University of Rochester Medical Center, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT06216301

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Namoota walitti qabaa jiraSadarkaa 1
  • University of Rochester, Rochester
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04297605

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster · Miili 10 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Namoota walitti qabaa jiraSadarkaa 2
  • University of Rochester, Rochester
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2025 · NCT06262321

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo Rochester keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.